Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade)
Source: SeekingAlpha
2026-01-14 17:33:04 ET
When Becton, Dickinson & Company ( BDX ) announced a solid divestment of its bioscience and diagnostic business to Waters ( WAT ) over the summer, I believed that the transaction was accretive to the shares, even as near-term earnings were set to take a hit. ...
Read the full article on Seeking Alpha
For further details see:
Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade)
Waters Corporation
NASDAQ: WAT
WAT Trading
-2.95% G/L:
$287.63 Last:
551,298 Volume:
$293.54 Open:
WAT Latest News
March 09, 2026 08:00:00 am
Waters Flagship ARES?G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
WAT Stock Data
$19,462,563,078
58,952,201
0.08%
377
N/A
Biotechnology & Life Sciences
Healthcare
US
Milford
